Posted on 07/29/2022 9:50:56 AM PDT by ransomnote
https://www.healthline.com/health/drugs/hydroxyurea-oral-capsule
EXTREMELY nasty drug, belongs to a class of drugs known as antimetabolites, in other words, the same class as other anti-cancer cellular toxins such as methotrexate ...
While they're at it, they might as well blame me for not getting vaccinated.
This is getting more and more out of control by the hour. But it ain't over: as time moves on, we're all still waiting for the more serious, long-term effects to kick in.
I am generally a very optimistic guy. But mark my words: Those sour long-term effects WILL come.
Obama is in charge and he is the devil. I’m not sure even Trump can save America. The hatred by some state governors and federal lawmakers against this country is mind boggling.
Following that link to the NIH study, you should dig into the details:
From:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647674/
“The total number of reported COVID-19 cases diagnosed in patients with sickle cell disease worldwide is 359. Of the reported study population, 212 were 19 or older and the remaining 147 were 18 or below making them pediatric cases (Figure 1). Of the patients reported, 164 were male, 190 were female, and 5 did not answer and/or identify with either gender (Figure 2). Of the 359 total reported, 192 were taking hydroxyurea prior to their COVID-19 diagnosis (53.8 %) (Figure 3). Of the 192 patients taking hydroxyurea, 86 were male and 106 were female (Figure 4). Of the 192 patients taking hydroxyurea, 81 were 18 years old or younger and 111 were age 19 years or older (Figure 5). Of the 359 patients reported as of August 28th, 2020, there have been 16 fatalities. Of those 16 fatalities, 7 were taking hydroxyurea and 9 were not. When compared, the mortality rate of total patients taking hydroxyurea (192) is 3.65% compared to a mortality rate of 5.39% for total patients not taking hydroxyurea (167) (Figures 6 & 7).”
I’m not sure you have a large enough data pool to make a conclusion on this, especially with the number of other factors & variables at play (individuals age, general health, other medications/treatments being administered, etc.). I’m not saying it wouldn’t warrant review, but one one patient living vs. dying (8/8) show no affect of the hydroxurea?
Also, not looking at the ages beyond “are they above or below 18 years old” is about useless when evaluating a disease that mainly affects the elderly groups more than those under 50.
Just my $.03 (Bidenflation...)
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.